Literature DB >> 27614245

The role of acetoacetate in Amadori product formation of human serum albumin.

Mousa Bohlooli1, Mansour Ghaffari-Moghaddam2, Mostafa Khajeh2, Gholamreza Shahraki-Fallah3, Batool Haghighi-Kekhaiye2, Nader Sheibani4.   

Abstract

Amadori product is an important and stable intermediate, which is produced during glycation process. It is a marker of hyperglycemia in diabetes mellitus, and its accumulation in the body contributes to microvascular complication of diabetes including diabetic nephropathy and retinopathy. In this study, the effect of acetoacetate on the formation of Amadori products and biophysical properties of human serum albumin (HSA), after incubation with glucose, was investigated using various methods. These included circular dichroism (CD), Fourier transform infrared (FTIR) spectroscopy, and UV-visible and fluorescence spectroscopy. Our results indicated that the production of Amadori products in HSA incubated with glucose (GHSA) was increased in the presence of acetoacetate. We also detected alterations in the secondary and tertiary structure of GHSA, which was increased in the presence of acetoacetate. These changes were attributed to the formation of covalent bonds between the carbonyl group of acetoacetate and the nucleophilic groups (lysine residues) of HSA. Thus, acetoacetate can enhance the production of Amadori products through formation of covalent bonds with biomaterials.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetoacetate; Amadori product; Diabetes mellitus; Glycated HSA; Ketone body; Prolonged incubation

Mesh:

Substances:

Year:  2016        PMID: 27614245      PMCID: PMC5217172          DOI: 10.1016/j.jphotobiol.2016.09.004

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  34 in total

1.  Conformational transitions of the three recombinant domains of human serum albumin depending on pH.

Authors:  M Dockal; D C Carter; F Rüker
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

Review 2.  Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes.

Authors:  L Laffel
Journal:  Diabetes Metab Res Rev       Date:  1999 Nov-Dec       Impact factor: 4.876

3.  Thermodynamics of a molten globule state of human serum albumin by 3-β-hydroxybutyrate as a ketone body.

Authors:  M Bohlooli; A A Moosavi-Movahedi; F Taghavi; M Habibi-Rezaei; A Seyedarabi; A A Saboury; F Ahmad
Journal:  Int J Biol Macromol       Date:  2012-12-19       Impact factor: 6.953

4.  The quantification of protein amino groups by the trinitrobenzenesulfonic acid method: a reexamination.

Authors:  P Cayot; G Tainturier
Journal:  Anal Biochem       Date:  1997-07-01       Impact factor: 3.365

5.  Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice.

Authors:  R S Clements; W G Robison; M P Cohen
Journal:  J Diabetes Complications       Date:  1998 Jan-Feb       Impact factor: 2.852

6.  Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus.

Authors:  Binish Arif; Jalaluddin M Ashraf; Jamal Ahmad; Zarina Arif; Khursheed Alam
Journal:  Arch Biochem Biophys       Date:  2012-04-10       Impact factor: 4.013

Review 7.  Advanced glycation endproducts--role in pathology of diabetic complications.

Authors:  Nessar Ahmed
Journal:  Diabetes Res Clin Pract       Date:  2005-01       Impact factor: 5.602

Review 8.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

9.  Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites.

Authors:  N Iberg; R Flückiger
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

10.  Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients.

Authors:  C G Schalkwijk; N Chaturvedi; H Twaafhoven; V W M van Hinsbergh; C D A Stehouwer
Journal:  Eur J Clin Invest       Date:  2002-07       Impact factor: 4.686

View more
  1 in total

Review 1.  Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin.

Authors:  Gian Mario Cortes; Maria Antonietta Marcialis; Flaminia Bardanzellu; Angelica Corrias; Vassilios Fanos; Michele Mussap
Journal:  Front Microbiol       Date:  2022-03-21       Impact factor: 6.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.